Childhood Soft Tissue Sarcoma: Clinical Trials

6 trials for Childhood Soft Tissue Sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 terminated. 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Recruiting 1
Phase 31Terminated 1

Follow Childhood Soft Tissue Sarcoma: new trials by email Literature Review of Childhood Soft Tissue Sarcoma trials Research Report on Childhood Soft Tissue Sarcoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas
Fludarabine, Cyclophosphamide, B7-H3-CAR T Cells - Sarcoma, Childhood Osteosarcoma
Phase 1RecruitingSt. Jude Children's Research Hospital422026-01-212026-02-09
Biomarkers of Resiliency In Childhood Cancer Surgery
Wearing Smartwatch, Patient Report Outcomes, Blood Draw - Pediatric Cancer, Neuroblastoma
RecruitingMayo Clinic402025-01-152026-09-14
Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer
filgrastim - Childhood Choroid Plexus Tumor, Childhood Medulloblastoma
Phase 3TerminatedBarbara Ann Karmanos Cancer Institute232013-08-012020-10-29
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
pharmacological study, laboratory biomarker analysis - Childhood Acute Lymphoblastic Leukemia, Childhood Rhabdomyosarcoma
CompletedChildren's Oncology Group1582008-02-012017-05-17
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
busulfan, melphalan, topotecan hydrochloride - Solid Tumor, Adult Central Nervous System Germ Cell Tumor
Phase 1CompletedCity of Hope Medical Center252007-02-262025-03-20
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
doxorubicin HCl liposome - Childhood Soft Tissue Sarcoma, Childhood Liver Cancer
Phase 1CompletedNational Cancer Institute (NCI)1999-07-012024-03-04

Narrower conditions

Wilms Tumor (5)  ·  Neuroblastoma (4)  ·  Medulloblastoma (3)  ·  Neuroectodermal Tumors, Primitive, Peripheral (3)  ·  Sarcoma (3)  ·  Sarcoma, Ewing (3)  ·  Astrocytoma (2)  ·  Brain Neoplasms (2)  ·  Choroid Plexus Neoplasms (2)  ·  Familial ependymoma (2)  ·  Neoplasms (2)  ·  Optic Nerve Glioma (2)  ·  Osteosarcoma (2)  ·  Testicular Neoplasms (2)  ·  Bone Neoplasms (1)

Broader conditions

Neoplasms by Histologic Type (6)  ·  Neoplasms, Connective and Soft Tissue (6)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Kidney Diseases (5)  ·  Kidney Neoplasms (5)  ·  Male Urogenital Diseases (5)  ·  Neoplasms by Site (5)  ·  Neoplasms, Bone Tissue (5)  ·  Neoplasms, Complex and Mixed (5)  ·  Neoplasms, Connective Tissue (5)  ·  Neoplasms, Germ Cell and Embryonal (5)  ·  Neoplasms, Glandular and Epithelial (5)  ·  Neoplasms, Nerve Tissue (5)

Interventions

Filgrastim (2)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  Blood Specimen Collection (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Cyclophosphamide (1)  ·  Melphalan (1)  ·  Radiotherapy (1)  ·  Topotecan (1)  ·  Transplantation (1)  ·  fludarabine (1)  ·  trioctyl phosphine oxide (1)

Sponsors

Barbara Ann Karmanos Cancer Institute (1)  ·  Children's Oncology Group (1)  ·  City of Hope Medical Center (1)  ·  Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)  ·  St. Jude Children's Research Hospital (1)

Countries

United States (6)  ·  Australia (1)  ·  Canada (1)

Top investigators

Anna Pawlowska, MD (1)  ·  Elizabeth Lowe (1)  ·  Jeffrey Skolnik (1)  ·  Maxim Yankelevich (1)  ·  Rebecca Epperly, MD (1)  ·  Stephanie Polites, M.D., M.P.H. (1)

NIH funding

P30CA022453 (1), U10CA098543 (1)